Merck-Moderna Vaccine Cuts Melanoma Death or Recurrence Risk 42%
Trial data show the mRNA vaccine, combined with a widely used immunotherapy, cut melanoma disease-spread risk by 38%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.